Bio SB performs R&D, production, distribution of antibodies and detection systems for immunohistochemistry (IHC), including environmentally friendly ancillaries, unique IVD validated antibodies, detection systems and equipment. Our portfolio includes products for immunohistochemistry (IHC) immunocytochemistry (ICC), Immunofluorescence (IF), chromogenic in situ hybridization (CISH) and fluorescent in situ hybridization (FISH) technologies that meet the highest international standards for applications in molecular pathology, cancer research, microbiology, immunology and genetics. Bio SB manufactures and develops products in accordance with FDA QSR 21 CFR Part 820 cGMP, CE IVD and ISO13485:2016 certifications.
|May 27th – 29th, 2022||ASMS, American Society for Mohs Surgery: Orlando , FL||Website|
|May 12th – 14th, 2022||ACMS, American Collège of Mohs Surgery: Philadelphia, PA||Website|
|April 28th – May 1st, 2022||LXIII Mexican Congress of Pathology, Guadalajara, Mexico||Website|
|April 23rd, 1:30 PM||Our Ice in Paradise Sk8 to Elimin8 Cancer 2022||Website|
|April 10th – 13th, 2022||AACR: New Orleans, LA||Website|
|March 21st – 23rd,2022||USCAP: Los Angeles Convention Center||Website|